TNYA Novinky na Forexu
Tenaya Therapeutics Says FDA Clears IND Application And Initiation Of Phase 1 For TN-301
Biotechnology company Tenaya Therapeutics, Inc. (TNYA) announced Tuesday the clearance of its Investigational New Drug (IND) application to begin clinical testing of TN-301 by the U.S. Food and Drug Administration (FDA).
RTTNews
|
Před 858 dny
